Morgan Stanley
PRPH

Morgan Stanley’s ProPhase Labs PRPH Stock Holding History

Morgan Stanley’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-919
Closed -$411 – 8455
2025
Q4 		$411 Buy
919
+2
+0.2% +$6 ﹤0.01% 7536
2025
Q3 		$4.2K Hold
917
– – ﹤0.01% 7138
2025
Q2 		$3.59K Hold
917
– – ﹤0.01% 7117
2025
Q1 		$3.71K Hold
917
– – ﹤0.01% 7060
2024
Q4 		$6.94K Buy
917
+479
+109% +$6.72K ﹤0.01% 6915
2024
Q3 		$10.6K Hold
438
– – ﹤0.01% 6704
2024
Q2 		$18.3K Hold
438
– – ﹤0.01% 6494
2024
Q1 		$28.3K Sell
438
-80
-15% -$4.05K ﹤0.01% 6393
2023
Q4 		$23.4K Buy
518
+25
+5% +$1.14K ﹤0.01% 6405
2023
Q3 		$21.5K Sell
493
-42
-8% -$2.46K ﹤0.01% 6458
2023
Q2 		$38.9K Buy
535
+5
+0.9% +$407 ﹤0.01% 6317
2023
Q1 		$40.4K Sell
530
-938
-64% -$75.6K ﹤0.01% 6361
2022
Q4 		$141K Buy
1,468
+494
+51% +$53.4K ﹤0.01% 5815
2022
Q3 		$110K Buy
974
+18
+2% +$2.09K ﹤0.01% 6029
2022
Q2 		$121K Buy
956
+667
+231% +$58.6K ﹤0.01% 6176
2022
Q1 		$20K Sell
289
-334
-54% -$23.2K ﹤0.01% 7151
2021
Q4 		$45K Sell
623
-408
-40% -$25.4K ﹤0.01% 6861
2021
Q3 		$54K Buy
1,031
+148
+17% +$8.81K ﹤0.01% 6684
2021
Q2 		$55K Sell
883
-176
-17% -$9.88K ﹤0.01% 6629
2021
Q1 		$78K Buy
1,059
+826
+355% +$79.3K ﹤0.01% 6142
2020
Q4 		$21K Buy
233
+148
+174% +$12.4K ﹤0.01% 6424
2020
Q3 		$3K Hold
85
– – ﹤0.01% 6518
2020
Q2 		$1K Hold
85
– – ﹤0.01% 6527
2020
Q1 		$2K Hold
85
– – ﹤0.01% 6397
2019
Q4 		$2K Hold
85
– – ﹤0.01% 6507
2019
Q3 		$2K Hold
85
– – ﹤0.01% 6486
2019
Q2 		$2K Hold
85
– – ﹤0.01% 6466
2019
Q1 		$3K Hold
85
– – ﹤0.01% 6406
2018
Q4 		$3K Sell
85
-1
-1% -$30 ﹤0.01% 6379
2018
Q3 		$3K Sell
86
-5
-5% -$151 ﹤0.01% 6514
2018
Q2 		$3K Buy
91
+6
+7% +$199 ﹤0.01% 6511
2018
Q1 		$3K Hold
85
– – ﹤0.01% 6463
2017
Q4 		$2K Buy
85
+80
+1,600% +$1.75K ﹤0.01% 6450
2017
Q3 		$0 Hold
5
– – ﹤0.01% 6589
2017
Q2 		$0 Hold
5
– – ﹤0.01% 6633
2017
Q1 		$0 Hold
5
– – ﹤0.01% 6600
2016
Q4 		$0 Hold
5
– – ﹤0.01% 6556
2016
Q3 		$0 Hold
5
– – ﹤0.01% 6548
2016
Q2 		$0 Sell
5
-3
-38% -$40 ﹤0.01% 6617
2016
Q1 		$0 Sell
8
-68,240
-100% -$854K ﹤0.01% 6674
2015
Q4 		$1.02M Buy
68,248
+3
+0% +$43 ﹤0.01% 4029
2015
Q3 		$1.08M Sell
68,245
-3
-0% -$45 ﹤0.01% 4040
2015
Q2 		$921K Buy
68,248
+5
+0% +$67 ﹤0.01% 4268
2015
Q1 		$894K Hold
68,243
– – ﹤0.01% 4214
2014
Q4 		$996K Buy
68,243
+68,240
+2,274,667% +$944K ﹤0.01% 4150
2014
Q3 		$0 Hold
3
– – ﹤0.01% 6639
2014
Q2 		$0 Hold
3
– – ﹤0.01% 6578
2014
Q1 		$0 Buy
+3
New +$57 ﹤0.01% 6526

Other funds holding PRPH

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Morgan Stanley's PRPH Position: Q1 2026 in Review

Morgan Stanley sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 919 shares — an estimated $411 sold.

Morgan Stanley first reported a position in PRPH in Q1 2014 and held it in 48 quarters. The position peaked at $1.08M in Q3 2015. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • Morgan Stanley reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 919 ProPhase Labs shares in Q1 2026, an estimated $411.
  • Morgan Stanley first reported a position in ProPhase Labs in Q1 2014 and held it in 48 quarters.
  • Morgan Stanley's ProPhase Labs position peaked at $1.08M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.